Cartesian Therapeutics
RNAC
RNAC
69 hedge funds and large institutions have $58.3M invested in Cartesian Therapeutics in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 32 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
69
Holders Change
-11
Holders Change %
-13.75%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
14
Reduced
32
Closed
15
Calls
$17K
Puts
–
Net Calls
+$17K
Net Calls Change
+$10K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.32M |
| 2 |
Millennium Management
New York
|
+$506K |
| 3 |
Invesco
Atlanta,
Georgia
|
+$124K |
| 4 |
Jane Street
New York
|
+$67.9K |
| 5 |
EAM
Erste Asset Management
Vienna,
Austria
|
+$55.4K |
Top Sellers
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$14.2M |
| 2 |
Goldman Sachs
New York
|
-$5.99M |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$1.54M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$604K |
| 5 |
MAP
Madison Avenue Partners
New York
|
-$402K |
